Behrad Derakhshan, the Chief Business Officer of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), recently sold 10,000 shares of the company's common stock. The shares were sold at an average price of $30.

Introduction: The Regulatory Shift Impacting Mergers The U.S. Federal Trade Commission’s (FTC) newly enacted merger filing rule has introduced significant changes to the regulatory landscape. Taking ...

The ICE U.S. Dollar Index was up 0.4% in recent trading after the latest reports about President Donald Trump's tariff plans.

The unemployment rate, which is derived from a separate survey, declined to 4% from 4.1% the prior month. Economists expected ...

In Money today: the best mortgage rates and where they're expected to go this year following the base rate cut; Netflix has ...

Palantir's high valuation and market risks make it a risky investment, with a potential 60-70% downside from current price ...

A slight cooling off of the labor market saw job creation falling behind expectations, but the unemployment rate dipped ...

New data from the accounting platform Xero should give American entrepreneurs a reason to be optimistic about 2025.

The company said the acquisition strengthens its fraud and risk management (FRM) capabilities and drives product-led ...

Shortlisted entries will appear in our report in September, alongside our ranking of the most innovative law firms ...

Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.

Q4 2024 Earnings Call Transcript February 6, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is ...